http://www.stockbloghub.com Start Your Investing Research Here! Thu, 24 May 2012 23:16:35 +0000 en hourly 1 http://wordpress.org/?v=3.3.2 http://www.stockbloghub.com/2009/11/09/rx-big-pharma-and-biotech-industry-outlook/20146 http://www.stockbloghub.com/2009/11/09/rx-big-pharma-and-biotech-industry-outlook/20146#comments Mon, 09 Nov 2009 23:57:38 +0000 Shawn http://www.stockbloghub.com/?p=20146 http://www.stockbloghub.com/2009/11/09/rx-big-pharma-and-biotech-industry-outlook/20146/feed 0 http://www.stockbloghub.com/2009/10/16/abt-abbott-laboratories-outperforms-raises/17688 http://www.stockbloghub.com/2009/10/16/abt-abbott-laboratories-outperforms-raises/17688#comments Fri, 16 Oct 2009 22:56:10 +0000 vitalstocks http://www.stockbloghub.com/?p=17688 http://www.stockbloghub.com/2009/10/16/abt-abbott-laboratories-outperforms-raises/17688/feed 0 http://www.stockbloghub.com/2009/10/13/nktr-nektar-therapeutics-presents-favorable-phase-ii-trial-data/17491 http://www.stockbloghub.com/2009/10/13/nktr-nektar-therapeutics-presents-favorable-phase-ii-trial-data/17491#comments Tue, 13 Oct 2009 19:35:44 +0000 vitalstocks http://www.stockbloghub.com/?p=17491 http://www.stockbloghub.com/2009/10/13/nktr-nektar-therapeutics-presents-favorable-phase-ii-trial-data/17491/feed 0 http://www.stockbloghub.com/2009/10/09/nvs-novartis-acquires-antibiotic-rights/17329 http://www.stockbloghub.com/2009/10/09/nvs-novartis-acquires-antibiotic-rights/17329#comments Fri, 09 Oct 2009 17:28:49 +0000 vitalstocks http://www.stockbloghub.com/?p=17329 http://www.stockbloghub.com/2009/10/09/nvs-novartis-acquires-antibiotic-rights/17329/feed 0 http://www.stockbloghub.com/2009/10/03/azn-astrazeneca-and-nektar-therapeutics-deal-to-add-value/16545 http://www.stockbloghub.com/2009/10/03/azn-astrazeneca-and-nektar-therapeutics-deal-to-add-value/16545#comments Sat, 03 Oct 2009 21:41:41 +0000 vitalstocks http://www.stockbloghub.com/?p=16545 http://www.stockbloghub.com/2009/10/03/azn-astrazeneca-and-nektar-therapeutics-deal-to-add-value/16545/feed 0 http://www.stockbloghub.com/2009/09/24/t-top-income-equity-funds-mutual-fund-commentary/15996 http://www.stockbloghub.com/2009/09/24/t-top-income-equity-funds-mutual-fund-commentary/15996#comments Thu, 24 Sep 2009 20:15:32 +0000 vitalstocks http://www.stockbloghub.com/?p=15996 http://www.stockbloghub.com/2009/09/24/t-top-income-equity-funds-mutual-fund-commentary/15996/feed 0 http://www.stockbloghub.com/2009/09/22/azn-astrazeneca-signs-licensing-deal-with-nektar-therapeutics/15824 http://www.stockbloghub.com/2009/09/22/azn-astrazeneca-signs-licensing-deal-with-nektar-therapeutics/15824#comments Tue, 22 Sep 2009 20:50:19 +0000 vitalstocks http://www.stockbloghub.com/?p=15824 http://www.stockbloghub.com/2009/09/22/azn-astrazeneca-signs-licensing-deal-with-nektar-therapeutics/15824/feed 0 http://www.stockbloghub.com/2009/09/16/wye-positive-data-from-wyeth-drug/15379 http://www.stockbloghub.com/2009/09/16/wye-positive-data-from-wyeth-drug/15379#comments Wed, 16 Sep 2009 22:30:45 +0000 vitalstocks http://www.stockbloghub.com/?p=15379 http://www.stockbloghub.com/2009/09/16/wye-positive-data-from-wyeth-drug/15379/feed 0 http://www.stockbloghub.com/2009/09/16/thrx-theravance-earns-fda-approval-for-skin-infection-drug/15265 http://www.stockbloghub.com/2009/09/16/thrx-theravance-earns-fda-approval-for-skin-infection-drug/15265#comments Wed, 16 Sep 2009 16:22:12 +0000 vitalstocks http://www.stockbloghub.com/?p=15265 http://www.stockbloghub.com/2009/09/16/thrx-theravance-earns-fda-approval-for-skin-infection-drug/15265/feed 0 http://www.stockbloghub.com/2009/09/14/frx-forest-laboratories-presents-encouraging-data/15099 http://www.stockbloghub.com/2009/09/14/frx-forest-laboratories-presents-encouraging-data/15099#comments Mon, 14 Sep 2009 17:32:50 +0000 vitalstocks http://www.stockbloghub.com/?p=15099 http://www.stockbloghub.com/2009/09/14/frx-forest-laboratories-presents-encouraging-data/15099/feed 0 http://www.stockbloghub.com/2009/09/09/slxp-salix-pharmaceuticals-gets-marketing-approval/14785 http://www.stockbloghub.com/2009/09/09/slxp-salix-pharmaceuticals-gets-marketing-approval/14785#comments Thu, 10 Sep 2009 02:32:23 +0000 vitalstocks http://www.stockbloghub.com/?p=14785 http://www.stockbloghub.com/2009/09/09/slxp-salix-pharmaceuticals-gets-marketing-approval/14785/feed 0 http://www.stockbloghub.com/2009/09/02/jnj-johnson-johnson-responds-to-fda-questions-on-antibiotic-drug-trials/14144 http://www.stockbloghub.com/2009/09/02/jnj-johnson-johnson-responds-to-fda-questions-on-antibiotic-drug-trials/14144#comments Wed, 02 Sep 2009 20:39:45 +0000 vitalstocks http://www.stockbloghub.com/?p=14144 http://www.stockbloghub.com/2009/09/02/jnj-johnson-johnson-responds-to-fda-questions-on-antibiotic-drug-trials/14144/feed 0 http://www.stockbloghub.com/2009/08/26/ach-top-income-equity-funds-mutual-fund-commentary/13436 http://www.stockbloghub.com/2009/08/26/ach-top-income-equity-funds-mutual-fund-commentary/13436#comments Wed, 26 Aug 2009 16:06:28 +0000 vitalstocks http://www.stockbloghub.com/?p=13436 http://www.stockbloghub.com/2009/08/26/ach-top-income-equity-funds-mutual-fund-commentary/13436/feed 0 http://www.stockbloghub.com/2009/08/25/lgnd-ligand-pharmaceuticals-to-buy-neurogen/13310 http://www.stockbloghub.com/2009/08/25/lgnd-ligand-pharmaceuticals-to-buy-neurogen/13310#comments Tue, 25 Aug 2009 21:36:46 +0000 vitalstocks http://www.stockbloghub.com/?p=13310 http://www.stockbloghub.com/2009/08/25/lgnd-ligand-pharmaceuticals-to-buy-neurogen/13310/feed 0 http://www.stockbloghub.com/2009/08/19/gsk-pharma-majors-to-gain-from-india/12677 http://www.stockbloghub.com/2009/08/19/gsk-pharma-majors-to-gain-from-india/12677#comments Wed, 19 Aug 2009 22:21:16 +0000 vitalstocks http://www.stockbloghub.com/?p=12677 http://www.stockbloghub.com/2009/08/19/gsk-pharma-majors-to-gain-from-india/12677/feed 0 http://www.stockbloghub.com/2009/08/19/lly-lilly-discontinues-arzoxifene-trials/12728 http://www.stockbloghub.com/2009/08/19/lly-lilly-discontinues-arzoxifene-trials/12728#comments Wed, 19 Aug 2009 21:43:36 +0000 vitalstocks http://www.stockbloghub.com/?p=12728 http://www.stockbloghub.com/2009/08/19/lly-lilly-discontinues-arzoxifene-trials/12728/feed 0 http://www.stockbloghub.com/2009/08/14/wye-fdas-delay-cramps-wyeth/12522 http://www.stockbloghub.com/2009/08/14/wye-fdas-delay-cramps-wyeth/12522#comments Fri, 14 Aug 2009 23:46:16 +0000 vitalstocks http://www.stockbloghub.com/?p=12522 http://www.stockbloghub.com/2009/08/14/wye-fdas-delay-cramps-wyeth/12522/feed 0 http://www.stockbloghub.com/2009/06/09/pfe-pharmaceuticals-biotech-zacks-analyst-interviews/8072 http://www.stockbloghub.com/2009/06/09/pfe-pharmaceuticals-biotech-zacks-analyst-interviews/8072#comments Tue, 09 Jun 2009 18:48:22 +0000 vitalstocks http://www.stockbloghub.com/?p=8072 http://www.stockbloghub.com/2009/06/09/pfe-pharmaceuticals-biotech-zacks-analyst-interviews/8072/feed 0 http://www.stockbloghub.com/2009/06/08/wye-pharmaceuticals-biotech-industry-outlook/8043 http://www.stockbloghub.com/2009/06/08/wye-pharmaceuticals-biotech-industry-outlook/8043#comments Mon, 08 Jun 2009 22:05:06 +0000 vitalstocks http://www.stockbloghub.com/?p=8043 http://www.stockbloghub.com/2009/06/08/wye-pharmaceuticals-biotech-industry-outlook/8043/feed 0 http://www.stockbloghub.com/2009/05/09/mrk-drug-companies-a-powerhouse-of-profits/6849 http://www.stockbloghub.com/2009/05/09/mrk-drug-companies-a-powerhouse-of-profits/6849#comments Sat, 09 May 2009 23:36:21 +0000 InvestmentU http://www.stockbloghub.com/?p=6849 http://www.stockbloghub.com/2009/05/09/mrk-drug-companies-a-powerhouse-of-profits/6849/feed 0 http://www.stockbloghub.com/2009/03/13/wye-biotech-industry-industry-outlook/4310 http://www.stockbloghub.com/2009/03/13/wye-biotech-industry-industry-outlook/4310#comments Fri, 13 Mar 2009 22:00:19 +0000 vitalstocks http://www.stockbloghub.com/?p=4310 http://www.stockbloghub.com/2009/03/13/wye-biotech-industry-industry-outlook/4310/feed 0